1: Kumar S, Kumari N, Mittal RD, Ghoshal UC. Pepsinogen-II 100 bp ins/del gene_x000D_
polymorphism and its elevated circulating levels are associated with gastric_x000D_
cancer, particularly with Helicobacter pylori infection and intestinal_x000D_
metaplasia. Gastric Cancer. 2016 Jul;19(3):808-16. doi:_x000D_
10.1007/s10120-015-0550-8. Epub 2015 Oct 20. PubMed PMID: 26486507.
_x000D_
_x000D_
_x000D_
2: He C, Xu Q, Tu H, Sun L, Gong Y, Liu J, Yuan Y. Polymorphic rs9471643 and_x000D_
rs6458238 upregulate PGC transcription and protein expression in overdominant or _x000D_
dominant models. Mol Carcinog. 2016 May;55(5):586-99. doi: 10.1002/mc.22305. Epub_x000D_
2015 Apr 7. PubMed PMID: 25857852.
_x000D_
_x000D_
_x000D_
3: He CY, Sun LP, Xu Q, Liu JW, Jiang JY, Dong NN, Yuan Y. PGC TagSNP and its_x000D_
interaction with H. pylori and relation with gene expression in susceptibility to_x000D_
gastric carcinogenesis. PLoS One. 2014 Dec 31;9(12):e115955. doi:_x000D_
10.1371/journal.pone.0115955. eCollection 2014. PubMed PMID: 25551587; PubMed_x000D_
Central PMCID: PMC4281127.
_x000D_
_x000D_
_x000D_
4: Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, Zendehdel N, Aliasgari A,_x000D_
Rakhshani N, Stolte M, Shahidi SM. Pepsinogen II can be a potential surrogate_x000D_
marker of morphological changes in corpus before and after H. pylori eradication._x000D_
Biomed Res Int. 2014;2014:481607. doi: 10.1155/2014/481607. Epub 2014 Jun 17._x000D_
PubMed PMID: 25028655; PubMed Central PMCID: PMC4083213.
_x000D_
_x000D_
_x000D_
5: Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M,_x000D_
Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H,_x000D_
Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M. Cancer_x000D_
development based on chronic active gastritis and resulting gastric atrophy as_x000D_
assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer._x000D_
Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct_x000D_
3. PubMed PMID: 24009139.
_x000D_
_x000D_
_x000D_
6: Cao XY, Jia ZF, Jin MS, Cao DH, Kong F, Suo J, Jiang J. Serum pepsinogen II is_x000D_
a better diagnostic marker in gastric cancer. World J Gastroenterol. 2012 Dec_x000D_
28;18(48):7357-61. doi: 10.3748/wjg.v18.i48.7357. PubMed PMID: 23326145; PubMed_x000D_
Central PMCID: PMC3544042.
_x000D_
_x000D_
_x000D_
7: Tahara T, Shibata T, Okubo M, Yamashita H, Yoshioka D, Yonemura J, Maruyama N,_x000D_
Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Yamada H, Nakamura_x000D_
M, Arisawa T, Hirata I. Examination of serum pepsinogen in functional dyspepsia. _x000D_
Hepatogastroenterology. 2012 Nov-Dec;59(120):2516-22. doi: 10.5754/hge10604._x000D_
PubMed PMID: 23178618.
_x000D_
_x000D_
_x000D_
8: Zheng KC, Aoki K, Li XQ, Lin SG, Wu BS, Zhong WL, Chen TH, Lin S, You JW, Su_x000D_
C. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the_x000D_
residents of two cities in china with distinct mortality rates of gastric cancer._x000D_
Tohoku J Exp Med. 2012;228(4):289-94. PubMed PMID: 23117263.
_x000D_
_x000D_
_x000D_
9: He CY, Sun LP, Gong YH, Xu Q, Dong NN, Yuan Y. Serum pepsinogen II: a_x000D_
neglected but useful biomarker to differentiate between diseased and normal_x000D_
stomachs. J Gastroenterol Hepatol. 2011 Jun;26(6):1039-46. doi:_x000D_
10.1111/j.1440-1746.2011.06692.x. PubMed PMID: 21303408.
_x000D_
_x000D_
_x000D_
10: Sun LP, Gong YH, Dong NN, Wang L, Yuan Y. [Correlation of pepsinogen C (PGC) _x000D_
gene insertion/deletion polymorphism to PGC protein expression in gastric mucosa _x000D_
and serum]. Ai Zheng. 2009 May;28(5):487-92. Chinese. PubMed PMID: 19624876.
_x000D_
_x000D_
_x000D_
11: Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa T._x000D_
Serum biomarker tests are useful in delineating between patients with gastric_x000D_
atrophy and normal, healthy stomach. World J Gastroenterol. 2009 Feb_x000D_
21;15(7):853-9. PubMed PMID: 19230047; PubMed Central PMCID: PMC2653386.
_x000D_
_x000D_
_x000D_
12: Sun LP, Zhang Y, Liu YE, Chen W, Yuan Y. [Interaction between an_x000D_
insertion/deletion polymorphism in pepsinogen C and Helicobacter pylori infection_x000D_
in the development of gastric cancer]. Zhonghua Zhong Liu Za Zhi. 2008_x000D_
Sep;30(9):644-8. Chinese. PubMed PMID: 19173902.
_x000D_
_x000D_
_x000D_
13: Sun LP, Guo XL, Zhang Y, Chen W, Bai XL, Liu J, Yuan Y. Impact of pepsinogen _x000D_
C polymorphism on individual susceptibility to gastric cancer and its_x000D_
precancerous conditions in a Northeast Chinese population. J Cancer Res Clin_x000D_
Oncol. 2009 Aug;135(8):1033-9. doi: 10.1007/s00432-008-0539-3. Epub 2009 Jan 9._x000D_
PubMed PMID: 19132389.
_x000D_
_x000D_
_x000D_
14: Pinto-Correia AL, Pinto D, Pereira D, Rodrigues H, de Sousa JA, Sousa H,_x000D_
Sousa B, Sousa S, Lopes C, Medeiros R. Overall survival in women with breast_x000D_
cancer: the influence of pepsinogen C gene polymorphism. DNA Cell Biol. 2008_x000D_
Jun;27(6):333-6. doi: 10.1089/dna.2007.0713. PubMed PMID: 18447628.
_x000D_
_x000D_
_x000D_
15: Parthasarathy G, Maroju NK, Kate V, Ananthakrishnan N, Sridhar MG. Serum_x000D_
pepsinogen I and II levels in various gastric disorders with special reference to_x000D_
their use as a screening test for carcinoma stomach. Trop Gastroenterol. 2007_x000D_
Oct-Dec;28(4):166-70. PubMed PMID: 18416347.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Human Gastricsin(PGII),PGC Recombinant Protein” Cancel reply
Reviews
There are no reviews yet.